Macrolide therapy is associated with lower mortality in community-acquired bacteraemic pneumonia

Autor: Forest W. Arnold, Gustavo Lopardo, Timothy L. Wiemken, Robert Kelley, Paula Peyrani, William A. Mattingly, Charles Feldman, Martin Gnoni, Rosemeri Maurici, Julio A. Ramirez, Forest Arnold, Julio Ramirez, Kwabena Ayesu, Thomas File, Steven Burdette, Stephen Blatt, Marcos Restrepo, Jose Bordon, Peter Gross, Daniel Musher, Thomas Marrie, Karl Weiss, Jorge Roig, Harmut Lode, Tobias Welte, Stephano Aliberti, Francesco Blasi, Roberto Cosentini, Delfino Legnani, Fabio Franzetti, Nicola Montano, Giulia Cervi, Paolo Rossi, Antonio Voza, Belinda Ostrowsky, Alberto Pesci, Stefano Nava, Pierluigi Viale, Vanni Galavatti, Aruj Patricia, Carlos Dimas, Roberto Piro, Claudio Viscoli, Antoni Torres, Vincenzo Valenti, Daniel Portela Ojales, Maria Bodi, Jose Porras, Jordi Rello, Rosario Menendez, Daiana Stolz, Philipp Schuetz, Sebastian Haubitz, James Chalmers, Tom Fardon, Guillermo Benchetrit, Eduardo Rodriguez, Jorge Corral, Jose Gonzalez, Lautaro de Vedia, Carlos Luna, Jorge Martinez, Lucia Marzoratti, Maria Rodriguez, Alejandro Videla, Federico Saavedra, Horacio Lopez, Carlos Victorio, Fernando Riera, Patricio Jimenez, Patricia Fernandez, Maria Parada, Alejandro Díaz Fuenzalida, Raul Riquelme, Manuel Barros, Juan Manuel Luna, Ivan Toala, Guillermo Arbo Oze de Morvil, Ricardo Fernandez, Gonzalo Aiello, Pablo Alvarez, Ana Soca, Federico Arteta, Jose Delgado, Gur Levy, Ludwig Rivero, Benito Rodriguez, Mario Perez Mirabal, Marilyn Mateo, Myrna Mendoza

Background Community-acquired pneumonia (CAP) has a potential complication of bacteremia. The objective of this study was to define the clinical outcomes of patients with CAP and bacteremia treated with and without a macrolide. Materials and methods

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efae26af8c3809ca5337735b30343b1f
http://hdl.handle.net/10281/204206